Rabaja, Rezelle Jane R.
HRN: 15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2022
04/11/2022
IV
500mg
Q8
Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes